{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:13:11Z","timestamp":1770217991829,"version":"3.49.0"},"reference-count":116,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:p><jats:bold>Abstract\u2003<\/jats:bold>This article briefly reviews the concepts of immunodeficiency and immunomodulation as they relate to selected skin diseases in the dog and cat. Immunodeficiency states are uncommon and may be associated with a subnormal or down\u2010regulated immune system, including humoral deficiencies, such as IgA, and abnormal lymphocyte or neutrophil function. Establishing a causal relationship between a skin disease and presumed immunodeficient state has been difficult due to the rarity of such conditions, and the limited nature of the techniques used to characterise the immune system response. Severe combined immunodeficiency in dogs is a well characterised primary immunodeficiency state involving lymphocytes; retrovirus infection in cats may lead to an acquired immunodeficient state with some association with certain dermatological conditions although it remains unclear that infection is causally linked with disease. Immunomodulation usually implies stimulating the immune system along a beneficial pathway. Such a therapeutic approach may involve a wide variety of agents, for example intravenous immunoglobulin. There are few randomised controlled trials with veterinary patients that unequivocally demonstrate beneficial responses to immunomodulatory agents. Interferons are cytokines of major interest in human and veterinary medicine for their antiviral, anti\u2010tumour and immunomodulatory effects. The advent of veterinary\u2010licensed products containing recombinant interferon may enable demonstration of the efficacy of interferons for conditions such as canine papillomatosis and feline eosinophilic granuloma complex. Canine pyoderma has been treated with a number of presumed immunomodulatory agents with limited success. With more detailed knowledge of the pathogenesis of pyoderma it may be possible to develop efficacious immunomodulators.<\/jats:p>","DOI":"10.1111\/j.1365-3164.2004.00363.x","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T12:25:28Z","timestamp":1079612728000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunomodulation and immunodeficiency"],"prefix":"10.1111","volume":"15","author":[{"given":"Aiden P.","family":"Foster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(02)00369-3"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(00)00197-8"},{"key":"e_1_2_8_4_2","first-page":"100","volume-title":"Advances in Veterinary Dermatology","author":"Robinson A.","year":"2002"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200002000-00009"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(99)00165-8"},{"key":"e_1_2_8_7_2","first-page":"453","volume-title":"Cellular and Molecular Immunology","author":"Abbas A.K.","year":"2003"},{"key":"e_1_2_8_8_2","first-page":"425","volume-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway C.A.","year":"2001"},{"key":"e_1_2_8_9_2","first-page":"313","volume-title":"Immunology","author":"Weller I.","year":"2001"},{"key":"e_1_2_8_10_2","first-page":"398","volume-title":"Veterinary Immunology: An Introduction","author":"Tizard I.R.","year":"2000"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(94)50076-7"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(99)00059-8"},{"key":"e_1_2_8_13_2","first-page":"683","volume-title":"Infectious Diseases of the Dog and Cat.","author":"Giger U.","year":"1998"},{"key":"e_1_2_8_14_2","first-page":"381","volume-title":"Rook Wilson Ebling Textbook of Dermatology","author":"Atherton D.J.","year":"1992"},{"key":"e_1_2_8_15_2","first-page":"528","volume-title":"Current Veterinary Therapy XI. Small Animal Practice.","author":"Campbell K.L.","year":"1992"},{"key":"e_1_2_8_16_2","unstructured":"DeBoer D.J.Recognition and evaluation of the immunocompromised patient: bursting the bubble.Proceedings of the ESVD\/ECVD Annual Congress Copenhagen2001:125\u20138."},{"key":"e_1_2_8_17_2","first-page":"211","volume-title":"Advances in Veterinary Dermatology","author":"Thoday K.L.","year":"1993"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1984.tb15538.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1997.tb03473.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(86)90071-1"},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2460\/javma.1992.200.07.986","article-title":"Dermatologic disorders of Chinese shar\u2010peis: 58 cases (1981\u20131989)","volume":"200","author":"Miller W.H.","year":"1992","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1995.1036"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(85)90050-9"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)30965-2"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(01)00405-6"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.143.14.381"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(95)05434-8"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2000.tb03972.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(89)90113-X"},{"key":"e_1_2_8_30_2","first-page":"1622","article-title":"Deficiency of leukocyte surface glycoproteins Mo1, LFA\u20101 and Leu M5 in a dog with recurrent bacterial infections: an animal model","volume":"69","author":"Giger U.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(92)90050-Z"},{"key":"e_1_2_8_32_2","first-page":"443","article-title":"Canine granulocytopathy syndrome: neutrophil dysfunction in a dog with recurrent infections","volume":"166","author":"Renshaw H.W.","year":"1975","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_33_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.V29.4.452.452","article-title":"Cyclic neutropenia in grey collie dogs","volume":"29","author":"Lund J.E.","year":"1967","journal-title":"Blood"},{"key":"e_1_2_8_34_2","first-page":"600","article-title":"Congenital hypotrichosis with thymic aplasia in nine Birmese kittens","volume":"30","author":"Casal M.L.","year":"1994","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_8_35_2","first-page":"554","article-title":"The Chediak\u2013Higashi syndrome of cats","volume":"36","author":"Kramer J.W.","year":"1977","journal-title":"Laboratory Investigation"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.2002.63.11.1914"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(00)00193-8"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-33-6-494"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(99)00049-5"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(90)50164-3"},{"key":"e_1_2_8_41_2","unstructured":"Guagu\u00e8re E. Declercq J.Viral dermatoses. In:Guagu\u00e8re E. Pr\u00e9laud P. eds.A Practical Guide to Feline Dermatology.Paris: Merial 1999; 7:1\u201311."},{"key":"e_1_2_8_42_2","first-page":"213","article-title":"Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission","volume":"194","author":"Yamamoto J.K.","year":"1989","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_43_2","first-page":"194","article-title":"Feline immunodeficiency virus \u2013 disease associations","volume":"20","author":"Shaw S.E.","year":"1990","journal-title":"Australian Veterinary Practitioner"},{"key":"e_1_2_8_44_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2460\/ajvr.2000.61.158","article-title":"Fungal flora on cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukaemia virus","volume":"61","author":"Sierra P.","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/02681219280000321"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/02681219780001231"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.124.15.397"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1990.tb00760.x"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30191-8"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-5224.2000.3230169.x"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30126-8"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00175.x"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00042103"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(02)00385-0"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(02)00388-6"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01149.x"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70247-0"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01171.x"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01144.x"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(01)00556-8"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(01)00560-X"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00334-1"},{"key":"e_1_2_8_63_2","doi-asserted-by":"crossref","unstructured":"Parmiani G. Castelli C. Dalerba P.et al.Cancer immunotherapy with peptide\u2010based vaccines: what have we achieved? Where are we going?2002; 94:805\u201318.","DOI":"10.1093\/jnci\/94.11.805"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01152.x"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(02)00232-5"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70281-2"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri888"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(98)82005-6"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.106899"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni875"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni873"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70026-P"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00697.x"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70147-T"},{"key":"e_1_2_8_75_2","first-page":"581","volume-title":"Current Veterinary Therapy XII","author":"Helton\u2010Rhodes K.","year":"1995"},{"key":"e_1_2_8_76_2","first-page":"252","volume-title":"Muller and Kirk\u2019s Small Animal Dermatology","author":"Scott D.W.","year":"2001"},{"key":"e_1_2_8_77_2","unstructured":"Schwassman M.Uses of interferon.Dermatology Dialogue (AAVD Newsletter) Winter1999:9."},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1135(02)00173-6"},{"key":"e_1_2_8_79_2","first-page":"536","volume-title":"Kirk\u2019s Current Veterinary Therapy XIII. Small Animal Practice.","author":"White S.D.","year":"2000"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra993360"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.117824"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118640"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03377.x"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.117822"},{"key":"e_1_2_8_85_2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1997.210.11.1623","article-title":"Intravenous administration of human immune globulin in dogs with immune\u2010mediated hemolytic anemia","volume":"210","author":"Scott\u2010Montcrieff J.C.R.","year":"1997","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2002.220.197"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-33-4-355"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(97)00008-1"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(98)00130-5"},{"key":"e_1_2_8_90_2","first-page":"513","article-title":"Deep pyoderma in two German shepherd dogs associated with a cell\u2010mediated immunodeficiency","volume":"27","author":"Miller W.H.","year":"1991","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(95)05463-4"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1998.00105.x"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5288(95)90094-2"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(94)90003-5"},{"key":"e_1_2_8_95_2","first-page":"479","article-title":"Treatment of canine bacterial hypersensitivity by hyposensitisation with Staphylococcus aureus bacterin\u2010toxoid","volume":"21","author":"Pukay B.P.","year":"1985","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-0279(78)50105-6"},{"key":"e_1_2_8_97_2","unstructured":"Halliwell R.E.W.Levels of IgE and IgG antibody to staphylococcal antigens in normal dogs and in dogs with recurrent pyoderma. In:Proceedings of the Annual Members\u2019 Meeting of AAVD and ACVD Phoenix AZ 1987:5."},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(97)00029-9"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(97)00038-X"},{"key":"e_1_2_8_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.1997.tb00270.x"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0176-6724(87)80121-9"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0176-6724(84)80054-1"},{"key":"e_1_2_8_103_2","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1128\/iai.65.6.2346-2352.1997","article-title":"Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates","volume":"65","author":"Edwards V.M.","year":"1997","journal-title":"Infection and Immunity"},{"key":"e_1_2_8_104_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2460\/javma.1998.213.02.232","article-title":"Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma and dogs with a single episode of pyoderma","volume":"213","author":"Burkett G.","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_105_2","doi-asserted-by":"publisher","DOI":"10.3109\/08910609109140138"},{"key":"e_1_2_8_106_2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2460\/ajvr.1994.55.12.1690","article-title":"Immunomodulatory effects of staphylococcal antigen and antigen\u2013antibody complexes on canine mononuclear leukocytes","volume":"55","author":"DeBoer D.J.","year":"1994","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_8_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(02)00107-8"},{"key":"e_1_2_8_108_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3017.x"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(95)05519-3"},{"key":"e_1_2_8_110_2","first-page":"95","article-title":"Control of recurrent superficial pyoderma in the dog: part 1 \u2013 the value of immunomodulatory drugs and bacterins","volume":"2","author":"Curtis C.F.","year":"2000","journal-title":"CPD Veterinary Medicine"},{"key":"e_1_2_8_111_2","unstructured":"Hendricks A.Staphylococci and vaccines \u2013 past present and future.Proceedings of the British Veterinary Dermatology Study Group \u2013 Spring Meeting Birmingham2001:35\u201343."},{"key":"e_1_2_8_112_2","first-page":"611","volume-title":"Kirk\u2019s Current Veterinary Therapy XII. Small Animal Practice","author":"DeBoer D.J.","year":"1995"},{"key":"e_1_2_8_113_2","first-page":"335","volume-title":"Advances in Veterinary Dermatology","author":"DeBoer D.J.","year":"1990"},{"key":"e_1_2_8_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(02)00228-3"},{"key":"e_1_2_8_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1989.tb00325.x"},{"key":"e_1_2_8_116_2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2460\/ajvr.1990.51.04.636","article-title":"Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs","volume":"51","author":"DeBoer D.J.","year":"1990","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_8_117_2","unstructured":"Curtis C.F. Lamport A.I. Lloyd D.H.Blinded controlled study to investigate the efficacy of a staphylococcal autogenous bacterin for the control of canine idiopathic recurrent pyoderma.Proceedings of the 16th Annual Congress of ESVD\u2010ECVD Helsinki 1999:148."}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3164.2004.00363.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3164.2004.00363.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T16:10:36Z","timestamp":1734279036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3164.2004.00363.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1365-3164.2004.00363.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3164.2004.00363.x","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]},"assertion":[{"value":"2004-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}